These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30500936)

  • 1. Vaccination of guinea pigs with BCGΔBCG1419c transiently reduces hematogenous spread of M. tuberculosis to the spleen.
    Aceves-Sánchez MJ; Flores-Valdez MA; Shanley C; Orme I; Bielefeldt-Ohmann H
    Pathog Dis; 2018 Dec; 76(9):. PubMed ID: 30500936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination with BCGΔBCG1419c protects against pulmonary and extrapulmonary TB and is safer than BCG.
    Aceves-Sánchez MJ; Flores-Valdez MA; Pedroza-Roldán C; Creissen E; Izzo L; Silva-Angulo F; Dawson C; Izzo A; Bielefeldt-Ohmann H; Segura-Cerda CA; López-Romero W; Bravo-Madrigal J; Barrios-Payán JA; de la Cruz MÁ; Ares M; Jorge-Espinoza MG
    Sci Rep; 2021 Jun; 11(1):12417. PubMed ID: 34127755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs.
    Brandt L; Skeiky YA; Alderson MR; Lobet Y; Dalemans W; Turner OC; Basaraba RJ; Izzo AA; Lasco TM; Chapman PL; Reed SG; Orme IM
    Infect Immun; 2004 Nov; 72(11):6622-32. PubMed ID: 15501795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG ΔureC::hly Improves Protection against Tuberculosis.
    Gengenbacher M; Nieuwenhuizen N; Vogelzang A; Liu H; Kaiser P; Schuerer S; Lazar D; Wagner I; Mollenkopf HJ; Kaufmann SH
    mBio; 2016 May; 7(3):. PubMed ID: 27222470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosis.
    Sander P; Clark S; Petrera A; Vilaplana C; Meuli M; Selchow P; Zelmer A; Mohanan D; Andreu N; Rayner E; Dal Molin M; Bancroft GJ; Johansen P; Cardona PJ; Williams A; Böttger EC
    Vaccine; 2015 Mar; 33(11):1353-9. PubMed ID: 25657094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
    Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The BCGΔBCG1419c strain, which produces more pellicle in vitro, improves control of chronic tuberculosis in vivo.
    Pedroza-Roldán C; Guapillo C; Barrios-Payán J; Mata-Espinosa D; Aceves-Sánchez Mde J; Marquina-Castillo B; Hernández-Pando R; Flores-Valdez MA
    Vaccine; 2016 Sep; 34(40):4763-70. PubMed ID: 27546876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response elicited by two rBCG strains devoid of genes involved in c-di-GMP metabolism affect protection versus challenge with M. tuberculosis strains of different virulence.
    Segura-Cerda CA; Aceves-Sánchez MJ; Marquina-Castillo B; Mata-Espinoza D; Barrios-Payán J; Vega-Domínguez PJ; Pedroza-Roldán C; Bravo-Madrigal J; Vallejo-Cardona AA; Hernández-Pando R; Flores-Valdez MA
    Vaccine; 2018 Apr; 36(16):2069-2078. PubMed ID: 29550192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination of guinea pigs with nutritionally impaired avirulent mutants of Mycobacterium bovis protects against tuberculosis.
    De Lisle GW; Wilson T; Collins DM; Buddle BM
    Infect Immun; 1999 May; 67(5):2624-6. PubMed ID: 10225931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A second-generation recombinant BCG strain combines protection against murine tuberculosis with an enhanced safety profile in immunocompromised hosts.
    Valencia-Hernandez AM; Zhao G; Miranda-Hernandez S; Segura-Cerda CA; Pedroza-Roldan C; Seifert J; Aceves-Sanchez MJ; Burciaga-Flores M; Gutierrez-Ortega A; Del Pozo-Ramos L; Flores-Valdez MA; Kupz A
    Vaccine; 2024 Oct; 42(24):126291. PubMed ID: 39241355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis.
    Horwitz MA; Harth G
    Infect Immun; 2003 Apr; 71(4):1672-9. PubMed ID: 12654780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system.
    Bottai D; Frigui W; Clark S; Rayner E; Zelmer A; Andreu N; de Jonge MI; Bancroft GJ; Williams A; Brodin P; Brosch R
    Vaccine; 2015 May; 33(23):2710-8. PubMed ID: 25869896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the immunogenic capability of the BCG strains BCGΔBCG1419c and BCGΔBCG1416c in a three-dimensional human lung tissue model.
    Parasa VR; Rose J; Castillo-Diaz LA; Aceves-Sánchez MJ; Vega-Domínguez PJ; Lerm M; Flores-Valdez MA
    Vaccine; 2018 Mar; 36(14):1811-1815. PubMed ID: 29475763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
    Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
    Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral vaccination of guinea pigs with a Mycobacterium bovis bacillus Calmette-Guerin vaccine in a lipid matrix protects against aerosol infection with virulent M. bovis.
    Clark S; Cross ML; Nadian A; Vipond J; Court P; Williams A; Hewinson RG; Aldwell FE; Chambers MA
    Infect Immun; 2008 Aug; 76(8):3771-6. PubMed ID: 18519560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs.
    Yamamoto T; Lasco TM; Uchida K; Goto Y; Jeevan A; McFarland C; Ly L; Yamamoto S; McMurray DN
    Tuberculosis (Edinb); 2007 Mar; 87(2):155-65. PubMed ID: 17289434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
    Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis.
    Williams A; Hatch GJ; Clark SO; Gooch KE; Hatch KA; Hall GA; Huygen K; Ottenhoff TH; Franken KL; Andersen P; Doherty TM; Kaufmann SH; Grode L; Seiler P; Martin C; Gicquel B; Cole ST; Brodin P; Pym AS; Dalemans W; Cohen J; Lobet Y; Goonetilleke N; McShane H; Hill A; Parish T; Smith D; Stoker NG; Lowrie DB; Källenius G; Svenson S; Pawlowski A; Blake K; Marsh PD
    Tuberculosis (Edinb); 2005; 85(1-2):29-38. PubMed ID: 15687025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
    Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC
    Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.